Like M & As?

According to a report in WSJ, Johnson & Johnson is in talks

to buy U.S.-Swiss medical-equipment maker Synthes Inc. in a deal that could be valued at around $20 billion, according to people familiar with the matter. Should the two sides reach an accord, it would rank as one of the biggest health-care takeovers in recent years.

Synthes makes equipment that is used to treat spinal injuries, a business that is more resistant to external pressure than one revolving around more elective procedures.

We haven’t liked JNJ for a long time for a number of non-financial reasons. We think their management is inattentive to manufacturing processes at best, sloppy at worst.

But we really don’t like mergers and acquisitions as a way to make a company look bigger. They haven’t invented a product, or developed a drug, they just bought somebody who did. What do you think will happen to their management? The ones who actually developed these products?

The deal may fall through. Let’s hope it does. Those Swiss are smart cookies! Surely they can find a better company to partner with.


About InvestingforOne

I've been investing in various assets by myself using a discount broker for many years. Over that time, I've developed some theories that others might find useful. Plus, there is more to investing than money. Time, talent, work, friends, family all go into developing a good and satisfactory strategy.
This entry was posted in Uncategorized and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s